KKR Genetic Disorder L.P.
Insider CIK 1780408 · BBIO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-05-12 | 2025-05-14 | 6,000,000 | $34.20 | $205.20M | 13,260,971 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 6,000,000 | $32.96 | $197.76M | 19,260,971 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2024-09-13 | 2024-09-17 | 5,800,000 | $25.75 | $149.35M | 25,260,971 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2021-02-17 | 2021-02-17 | 3,450,000 | $60.47 | $208.62M | 31,060,971 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | S Sale | 2020-05-28 | 2020-06-01 | 2,389,690 | $33.39 | $79.79M | 34,510,971 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | C Conversion deriv | 2019-07-01 | 2019-07-03 | 50,446,451 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | C Conversion deriv | 2019-07-01 | 2019-07-03 | 81,022,727 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | C Conversion deriv | 2019-07-01 | 2019-07-03 | 36,246,893 | — | $0 | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | C Conversion | 2019-07-01 | 2019-07-03 | 34,253,561 | — | $0 | 34,253,561 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | P Buy | 2019-07-01 | 2019-07-03 | 2,647,100 | $17.00 | $45.00M | 36,900,661 | SEC↗ |